Premium
Bengaluru-based biopharmaceutical company PlasmaGen Biosciences Pvt. Ltd, backed by venture capital firm Eight Roads Ventures, is poised to break out from a stagnant revenue run-rate, as it shifts towards majority in-house manufacturing, top company officials informed VCCircle. While the company’s topline has been stuck in the range of Rs 100-110 crore ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
